Cognitive, Emotional, Physical and Psychosocial Effects of Panax Quinquefolius L
Phase 2
Completed
- Conditions
- MemoryLearningAttentionCognitionWell-Being
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2008-03-12
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 72
- Registration Number
- NCT00527969
- Locations
- ๐จ๐ฆ
PNL, Edmonton, Alberta, Canada
Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults
Phase 2
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-02-16
- Last Posted Date
- 2007-07-17
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 50
- Registration Number
- NCT00435968
- Locations
- ๐บ๐ธ
Hackensack University Medical Center, Hackensack, New Jersey, United States
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
Phase 3
Completed
- Conditions
- Upper Respiratory Infection
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2009-06-08
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 500
- Registration Number
- NCT00259831
- Locations
- ๐จ๐ฆ
The Capital Care Group Continuing Care facilities, Edmonton, Alberta, Canada
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
Phase 2
Completed
- Conditions
- Upper Respiratory Infection
- First Posted Date
- 2005-11-18
- Last Posted Date
- 2007-06-18
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 75
- Registration Number
- NCT00255307
- Locations
- ๐จ๐ฆ
Stollery Children's Hospital, Edmonton, Alberta, Canada
๐จ๐ฆMisericordia Child Health Clinic, Edmonton, Alberta, Canada
ยฉ Copyright 2025. All Rights Reserved by MedPath